Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol
- Autores
- Almonte, Maribel; Murillo, Jorge Raúl; Sánchez, Gloria Inés; González, Paula; Ferrera, Annabelle; Picconi, María Alejandra; Wiesner, Carolina; Cruz Valdez, Aurelio; Lazcano Ponce, Eduardo; Jerónimo, Jose; Ferreccio, Catterina; Kasamatsu, Elena; Mendoza, Laura; Rodríguez, Guillermo; Calderón, Alejandro; Venegas, Gino; Villagra, Verónica; Tatti, Silvio Alejandro; Fleider, Laura; Terán, Carolina; Baena, Armando; Hernández, María de la Luz; Rol, Mary Luz; Lucas, Eric; Barbier, Sylvaine; Ramírez, Arianis Tatiana; Arrossi, Silvina; Rodríguez, María Isabel; González, Emmanuel; Celis, Marcela; Martínez, Sandra; Salgado, Yuly; Ortega, Marina; Beracochea, Andrea Verónica; Pérez, Natalia; Rodriguez de la Peña, Margarita Mercedes; Ramón, María; Hernández Nevarez, Pilar; Arboleda Naranjo, Margarita; Cabrera, Yessy; Salgado, Brenda; García, Laura; Retana, Marco Antonio; Colucci, María Celeste; Arias-Stella, Javier; Bellido-Fuentes, Yenny; Bobadilla, María Liz; Olmedo, Gladys; Brito García, Ivone; Méndez Herrera, Armando; Cardinal, Lucía Helena; Flores, Betsy; Peñaranda, Jhacquelin; Martínez Better, Josefina; Soilán, Ana; Figueroa, Jacqueline; Caserta, Benedicta; Sosa, Carlos; Moreno, Adrián; Mural, Juan; Doimi, Franco; Giménez, Diana; Rodríguez, Hernando; Lora, Oscar; Luciani, Silvana; Broutet, Nathalie; Darragh, Teresa; Herrero, Rolando
- Año de publicación
- 2020
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Introduction Human papillomavirus (HPV) testing is replacing cytology in primary screening. Its limited specificity demands using a second (triage) test to better identify women at high-risk of cervical disease. Cytology represents the immediate triage but its low sensitivity might hamper HPV testing sensitivity, particularly in low-income and middle-income countries (LMICs), where cytology performance has been suboptimal. The ESTAMPA (EStudio multicéntrico de TAMizaje y triaje de cáncer de cuello uterino con pruebas del virus del PApiloma humano; Spanish acronym) study will: (1) evaluate the performance of different triage techniques to detect cervical precancer and (2) inform on how to implement HPV-based screening programmes in LMIC. Methods and analysis Women aged 30-64 years are screened with HPV testing and Pap across 12 study centres in Latin America. Screened positives have colposcopy with biopsy and treatment of lesions. Women with no evident disease are recalled 18 months later for another HPV test; those HPV-positive undergo colposcopy with biopsy and treatment as needed. Biological specimens are collected in different visits for triage testing, which is not used for clinical management. The study outcome is histological high-grade squamous intraepithelial or worse lesions (HSIL+) under the lower anogenital squamous terminology. About 50 000 women will be screened and 500 HSIL+ cases detected (at initial and 18 months screening). Performance measures (sensitivity, specificity and predictive values) of triage techniques to detect HSIL+ will be estimated and compared with adjustment by age and study centre. Ethics and dissemination The study protocol has been approved by the Ethics Committee of the International Agency for Research on Cancer (IARC), of the Pan American Health Organisation (PAHO) and by those in each participating centre. A Data and Safety Monitoring Board (DSMB) has been established to monitor progress of the study, assure participant safety, advice on scientific conduct and analysis and suggest protocol improvements. Study findings will be published in peer-reviewed journals and presented at scientific meetings. Trial registration number NCT01881659
Fil: Almonte, Maribel. International Agency For Research On Cancer; Francia
Fil: Murillo, Jorge Raúl. Pontificia Universidad Javeriana; Colombia
Fil: Sánchez, Gloria Inés. Universidad de Antioquia; Colombia
Fil: González, Paula. Agencia Costarricense de Investigaciones Biomédicas; Costa Rica
Fil: Ferrera, Annabelle. Universidad Nacional Autónoma de Honduras; Honduras
Fil: Picconi, María Alejandra. Dirección Nacional de Institutos de Investigación. Administración Nacional de Laboratorios e Institutos de Salud. Instituto Nacional de Enfermedades Infecciosas; Argentina
Fil: Wiesner, Carolina. Instituto Nacional de Cancerología; Colombia
Fil: Cruz Valdez, Aurelio. Instituto de Salud Pública de México; México
Fil: Lazcano Ponce, Eduardo. Instituto de Salud Pública de México; México
Fil: Jerónimo, Jose. Liga Peruana de Lucha Contra El Cancer; Perú
Fil: Ferreccio, Catterina. Pontificia Universidad Católica de Chile; Chile
Fil: Kasamatsu, Elena. Universidad Nacional de Asunción; Paraguay
Fil: Mendoza, Laura. Universidad Nacional de Asunción; Paraguay
Fil: Rodríguez, Guillermo. Comisión Honoraria de Lucha Contra El Cáncer; Uruguay
Fil: Calderón, Alejandro. Caja Costarricense de Seguro Social; Costa Rica
Fil: Venegas, Gino. Clínica Anglo Americana; Perú. Universidad de Piura (udep); Perú
Fil: Villagra, Verónica. Laboratorio Central de Salud Pública; Paraguay
Fil: Tatti, Silvio Alejandro. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
Fil: Fleider, Laura. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
Fil: Terán, Carolina. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia
Fil: Baena, Armando. International Agency for Research on Cancer; Francia
Fil: Hernández, María de la Luz. Sms-oncology; Países Bajos. International Agency for Research on Cancer; Francia
Fil: Rol, Mary Luz. International Agency for Research on Cancer; Francia
Fil: Lucas, Eric. International Agency for Research on Cancer; Francia
Fil: Barbier, Sylvaine. International Agency for Research on Cancer; Francia
Fil: Ramírez, Arianis Tatiana. International Agency for Research on Cancer; Francia
Fil: Arrossi, Silvina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Estudios de Estado y Sociedad; Argentina
Fil: Rodríguez, María Isabel. Universidad Nacional de Asunción; Paraguay
Fil: González, Emmanuel. Hospital Dr Enrique Baltodano Briceño; Costa Rica
Fil: Celis, Marcela. Instituto Nacional de Cancerología; Colombia
Fil: Martínez, Sandra. Instituto Nacional de Cancerología; Colombia
Fil: Salgado, Yuly. Instituto Nacional de Cancerología; Colombia
Fil: Ortega, Marina. Hospital Nacional; Paraguay. Ministerio de Salud Pública y Bienestar Social; Paraguay
Fil: Beracochea, Andrea Verónica. Centro de Salud Ciudad de la Costa; Uruguay. Hospital Policial; Uruguay
Fil: Pérez, Natalia. Hospital de Clinicas Dr. Manuel Quintela; Uruguay
Fil: Rodriguez de la Peña, Margarita Mercedes. Hospital Nacional Profesor Alejandro Posadas; Argentina
Fil: Ramón, María. Patología Oncológica Sac; Perú
Fil: Hernández Nevarez, Pilar. Instituto de Salud Pública de México; México
Fil: Arboleda Naranjo, Margarita. Instituto Colombiano de Medicina Tropical; Colombia
Fil: Cabrera, Yessy. Universidad Nacional Autónoma de Honduras; Honduras
Fil: Salgado, Brenda. Secretaría de Salud; Honduras
Fil: García, Laura. Centro Hospitalario Pereira Rossell; Uruguay
Fil: Retana, Marco Antonio. Caja Costarricense de Seguro Social; Costa Rica
Fil: Colucci, María Celeste. Dirección Nacional de Institutos de Investigación. Administración Nacional de Laboratorios e Institutos de Salud. Instituto Nacional de Enfermedades Infecciosas; Argentina
Fil: Arias-Stella, Javier. Instituto de Patología y Biología Molecular Arias Stella; Perú
Fil: Bellido-Fuentes, Yenny. Liga Peruana de Lucha Contra El Cancer; Perú
Fil: Bobadilla, María Liz. Laboratorio Central de Salud Pública; Paraguay
Fil: Olmedo, Gladys. Laboratorio Central de Salud Pública; Paraguay
Fil: Brito García, Ivone. Instituto de Salud Pública de México; México
Fil: Méndez Herrera, Armando. Instituto de Salud Pública de México; México
Fil: Cardinal, Lucía Helena. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
Fil: Flores, Betsy. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia
Fil: Peñaranda, Jhacquelin. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia
Fil: Martínez Better, Josefina. Ese Hospital Antonio Roldán Betancur; Colombia
Fil: Soilán, Ana. Ministerio de Salud Pública y Bienestar Social; Paraguay. Hospital Nacional; Paraguay
Fil: Figueroa, Jacqueline. Programa Nacional Contra El Cáncer; Honduras
Fil: Caserta, Benedicta. Centro Hospitalario Pereira Rossell; Uruguay
Fil: Sosa, Carlos. Hospital Monseñor Víctor Manuel Sanabria Martínez; Costa Rica
Fil: Moreno, Adrián. Hospital Nacional Profesor Alejandro Posadas; Argentina
Fil: Mural, Juan. Hospital Nacional Profesor Alejandro Posadas; Argentina
Fil: Doimi, Franco. Patología Oncológica Sac; Perú
Fil: Giménez, Diana. Ministerio de Salud Pública y Bienestar Social; Paraguay
Fil: Rodríguez, Hernando. Ministerio de Salud Pública y Bienestar Social; Paraguay
Fil: Lora, Oscar. Hospital Gineco-obstétrico y Neonatal "dr Jaime Sánchez Porcel"; Bolivia. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia
Fil: Luciani, Silvana. Pan American Health Organization; Estados Unidos
Fil: Broutet, Nathalie. Organizacion Mundial de la Salud; Argentina
Fil: Darragh, Teresa. University of California; Estados Unidos
Fil: Herrero, Rolando. Instituto Costarricense de Investigacion y Ensenanza En Nutricion y Salud Costa Rica; Costa Rica. International Agency For Research On Cancer; Francia - Materia
-
COLPOSCOPY
GYNAECOLOGICAL ONCOLOGY
MOLECULAR DIAGNOSTICS
PREVENTIVE MEDICINE
PUBLIC HEALTH
RISK MANAGEMENT - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/174712
Ver los metadatos del registro completo
id |
CONICETDig_07d84345d05a6215770a501b994ba144 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/174712 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocolAlmonte, MaribelMurillo, Jorge RaúlSánchez, Gloria InésGonzález, PaulaFerrera, AnnabellePicconi, María AlejandraWiesner, CarolinaCruz Valdez, AurelioLazcano Ponce, EduardoJerónimo, JoseFerreccio, CatterinaKasamatsu, ElenaMendoza, LauraRodríguez, GuillermoCalderón, AlejandroVenegas, GinoVillagra, VerónicaTatti, Silvio AlejandroFleider, LauraTerán, CarolinaBaena, ArmandoHernández, María de la LuzRol, Mary LuzLucas, EricBarbier, SylvaineRamírez, Arianis TatianaArrossi, SilvinaRodríguez, María IsabelGonzález, EmmanuelCelis, MarcelaMartínez, SandraSalgado, YulyOrtega, MarinaBeracochea, Andrea VerónicaPérez, NataliaRodriguez de la Peña, Margarita MercedesRamón, MaríaHernández Nevarez, PilarArboleda Naranjo, MargaritaCabrera, YessySalgado, BrendaGarcía, LauraRetana, Marco AntonioColucci, María CelesteArias-Stella, JavierBellido-Fuentes, YennyBobadilla, María LizOlmedo, GladysBrito García, IvoneMéndez Herrera, ArmandoCardinal, Lucía HelenaFlores, BetsyPeñaranda, JhacquelinMartínez Better, JosefinaSoilán, AnaFigueroa, JacquelineCaserta, BenedictaSosa, CarlosMoreno, AdriánMural, JuanDoimi, FrancoGiménez, DianaRodríguez, HernandoLora, OscarLuciani, SilvanaBroutet, NathalieDarragh, TeresaHerrero, RolandoCOLPOSCOPYGYNAECOLOGICAL ONCOLOGYMOLECULAR DIAGNOSTICSPREVENTIVE MEDICINEPUBLIC HEALTHRISK MANAGEMENThttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Introduction Human papillomavirus (HPV) testing is replacing cytology in primary screening. Its limited specificity demands using a second (triage) test to better identify women at high-risk of cervical disease. Cytology represents the immediate triage but its low sensitivity might hamper HPV testing sensitivity, particularly in low-income and middle-income countries (LMICs), where cytology performance has been suboptimal. The ESTAMPA (EStudio multicéntrico de TAMizaje y triaje de cáncer de cuello uterino con pruebas del virus del PApiloma humano; Spanish acronym) study will: (1) evaluate the performance of different triage techniques to detect cervical precancer and (2) inform on how to implement HPV-based screening programmes in LMIC. Methods and analysis Women aged 30-64 years are screened with HPV testing and Pap across 12 study centres in Latin America. Screened positives have colposcopy with biopsy and treatment of lesions. Women with no evident disease are recalled 18 months later for another HPV test; those HPV-positive undergo colposcopy with biopsy and treatment as needed. Biological specimens are collected in different visits for triage testing, which is not used for clinical management. The study outcome is histological high-grade squamous intraepithelial or worse lesions (HSIL+) under the lower anogenital squamous terminology. About 50 000 women will be screened and 500 HSIL+ cases detected (at initial and 18 months screening). Performance measures (sensitivity, specificity and predictive values) of triage techniques to detect HSIL+ will be estimated and compared with adjustment by age and study centre. Ethics and dissemination The study protocol has been approved by the Ethics Committee of the International Agency for Research on Cancer (IARC), of the Pan American Health Organisation (PAHO) and by those in each participating centre. A Data and Safety Monitoring Board (DSMB) has been established to monitor progress of the study, assure participant safety, advice on scientific conduct and analysis and suggest protocol improvements. Study findings will be published in peer-reviewed journals and presented at scientific meetings. Trial registration number NCT01881659Fil: Almonte, Maribel. International Agency For Research On Cancer; FranciaFil: Murillo, Jorge Raúl. Pontificia Universidad Javeriana; ColombiaFil: Sánchez, Gloria Inés. Universidad de Antioquia; ColombiaFil: González, Paula. Agencia Costarricense de Investigaciones Biomédicas; Costa RicaFil: Ferrera, Annabelle. Universidad Nacional Autónoma de Honduras; HondurasFil: Picconi, María Alejandra. Dirección Nacional de Institutos de Investigación. Administración Nacional de Laboratorios e Institutos de Salud. Instituto Nacional de Enfermedades Infecciosas; ArgentinaFil: Wiesner, Carolina. Instituto Nacional de Cancerología; ColombiaFil: Cruz Valdez, Aurelio. Instituto de Salud Pública de México; MéxicoFil: Lazcano Ponce, Eduardo. Instituto de Salud Pública de México; MéxicoFil: Jerónimo, Jose. Liga Peruana de Lucha Contra El Cancer; PerúFil: Ferreccio, Catterina. Pontificia Universidad Católica de Chile; ChileFil: Kasamatsu, Elena. Universidad Nacional de Asunción; ParaguayFil: Mendoza, Laura. Universidad Nacional de Asunción; ParaguayFil: Rodríguez, Guillermo. Comisión Honoraria de Lucha Contra El Cáncer; UruguayFil: Calderón, Alejandro. Caja Costarricense de Seguro Social; Costa RicaFil: Venegas, Gino. Clínica Anglo Americana; Perú. Universidad de Piura (udep); PerúFil: Villagra, Verónica. Laboratorio Central de Salud Pública; ParaguayFil: Tatti, Silvio Alejandro. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; ArgentinaFil: Fleider, Laura. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; ArgentinaFil: Terán, Carolina. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; BoliviaFil: Baena, Armando. International Agency for Research on Cancer; FranciaFil: Hernández, María de la Luz. Sms-oncology; Países Bajos. International Agency for Research on Cancer; FranciaFil: Rol, Mary Luz. International Agency for Research on Cancer; FranciaFil: Lucas, Eric. International Agency for Research on Cancer; FranciaFil: Barbier, Sylvaine. International Agency for Research on Cancer; FranciaFil: Ramírez, Arianis Tatiana. International Agency for Research on Cancer; FranciaFil: Arrossi, Silvina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Estudios de Estado y Sociedad; ArgentinaFil: Rodríguez, María Isabel. Universidad Nacional de Asunción; ParaguayFil: González, Emmanuel. Hospital Dr Enrique Baltodano Briceño; Costa RicaFil: Celis, Marcela. Instituto Nacional de Cancerología; ColombiaFil: Martínez, Sandra. Instituto Nacional de Cancerología; ColombiaFil: Salgado, Yuly. Instituto Nacional de Cancerología; ColombiaFil: Ortega, Marina. Hospital Nacional; Paraguay. Ministerio de Salud Pública y Bienestar Social; ParaguayFil: Beracochea, Andrea Verónica. Centro de Salud Ciudad de la Costa; Uruguay. Hospital Policial; UruguayFil: Pérez, Natalia. Hospital de Clinicas Dr. Manuel Quintela; UruguayFil: Rodriguez de la Peña, Margarita Mercedes. Hospital Nacional Profesor Alejandro Posadas; ArgentinaFil: Ramón, María. Patología Oncológica Sac; PerúFil: Hernández Nevarez, Pilar. Instituto de Salud Pública de México; MéxicoFil: Arboleda Naranjo, Margarita. Instituto Colombiano de Medicina Tropical; ColombiaFil: Cabrera, Yessy. Universidad Nacional Autónoma de Honduras; HondurasFil: Salgado, Brenda. Secretaría de Salud; HondurasFil: García, Laura. Centro Hospitalario Pereira Rossell; UruguayFil: Retana, Marco Antonio. Caja Costarricense de Seguro Social; Costa RicaFil: Colucci, María Celeste. Dirección Nacional de Institutos de Investigación. Administración Nacional de Laboratorios e Institutos de Salud. Instituto Nacional de Enfermedades Infecciosas; ArgentinaFil: Arias-Stella, Javier. Instituto de Patología y Biología Molecular Arias Stella; PerúFil: Bellido-Fuentes, Yenny. Liga Peruana de Lucha Contra El Cancer; PerúFil: Bobadilla, María Liz. Laboratorio Central de Salud Pública; ParaguayFil: Olmedo, Gladys. Laboratorio Central de Salud Pública; ParaguayFil: Brito García, Ivone. Instituto de Salud Pública de México; MéxicoFil: Méndez Herrera, Armando. Instituto de Salud Pública de México; MéxicoFil: Cardinal, Lucía Helena. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; ArgentinaFil: Flores, Betsy. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; BoliviaFil: Peñaranda, Jhacquelin. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; BoliviaFil: Martínez Better, Josefina. Ese Hospital Antonio Roldán Betancur; ColombiaFil: Soilán, Ana. Ministerio de Salud Pública y Bienestar Social; Paraguay. Hospital Nacional; ParaguayFil: Figueroa, Jacqueline. Programa Nacional Contra El Cáncer; HondurasFil: Caserta, Benedicta. Centro Hospitalario Pereira Rossell; UruguayFil: Sosa, Carlos. Hospital Monseñor Víctor Manuel Sanabria Martínez; Costa RicaFil: Moreno, Adrián. Hospital Nacional Profesor Alejandro Posadas; ArgentinaFil: Mural, Juan. Hospital Nacional Profesor Alejandro Posadas; ArgentinaFil: Doimi, Franco. Patología Oncológica Sac; PerúFil: Giménez, Diana. Ministerio de Salud Pública y Bienestar Social; ParaguayFil: Rodríguez, Hernando. Ministerio de Salud Pública y Bienestar Social; ParaguayFil: Lora, Oscar. Hospital Gineco-obstétrico y Neonatal "dr Jaime Sánchez Porcel"; Bolivia. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; BoliviaFil: Luciani, Silvana. Pan American Health Organization; Estados UnidosFil: Broutet, Nathalie. Organizacion Mundial de la Salud; ArgentinaFil: Darragh, Teresa. University of California; Estados UnidosFil: Herrero, Rolando. Instituto Costarricense de Investigacion y Ensenanza En Nutricion y Salud Costa Rica; Costa Rica. International Agency For Research On Cancer; FranciaBMJ Publishing Group2020-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/174712Almonte, Maribel; Murillo, Jorge Raúl; Sánchez, Gloria Inés; González, Paula; Ferrera, Annabelle; et al.; Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol; BMJ Publishing Group; BMJ Open; 10; 5; 5-2020; 1-142044-6055CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1136/bmjopen-2019-035796info:eu-repo/semantics/altIdentifier/url/https://bmjopen.bmj.com/content/10/5/e035796info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:45:43Zoai:ri.conicet.gov.ar:11336/174712instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:45:44.133CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol |
title |
Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol |
spellingShingle |
Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol Almonte, Maribel COLPOSCOPY GYNAECOLOGICAL ONCOLOGY MOLECULAR DIAGNOSTICS PREVENTIVE MEDICINE PUBLIC HEALTH RISK MANAGEMENT |
title_short |
Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol |
title_full |
Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol |
title_fullStr |
Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol |
title_full_unstemmed |
Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol |
title_sort |
Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol |
dc.creator.none.fl_str_mv |
Almonte, Maribel Murillo, Jorge Raúl Sánchez, Gloria Inés González, Paula Ferrera, Annabelle Picconi, María Alejandra Wiesner, Carolina Cruz Valdez, Aurelio Lazcano Ponce, Eduardo Jerónimo, Jose Ferreccio, Catterina Kasamatsu, Elena Mendoza, Laura Rodríguez, Guillermo Calderón, Alejandro Venegas, Gino Villagra, Verónica Tatti, Silvio Alejandro Fleider, Laura Terán, Carolina Baena, Armando Hernández, María de la Luz Rol, Mary Luz Lucas, Eric Barbier, Sylvaine Ramírez, Arianis Tatiana Arrossi, Silvina Rodríguez, María Isabel González, Emmanuel Celis, Marcela Martínez, Sandra Salgado, Yuly Ortega, Marina Beracochea, Andrea Verónica Pérez, Natalia Rodriguez de la Peña, Margarita Mercedes Ramón, María Hernández Nevarez, Pilar Arboleda Naranjo, Margarita Cabrera, Yessy Salgado, Brenda García, Laura Retana, Marco Antonio Colucci, María Celeste Arias-Stella, Javier Bellido-Fuentes, Yenny Bobadilla, María Liz Olmedo, Gladys Brito García, Ivone Méndez Herrera, Armando Cardinal, Lucía Helena Flores, Betsy Peñaranda, Jhacquelin Martínez Better, Josefina Soilán, Ana Figueroa, Jacqueline Caserta, Benedicta Sosa, Carlos Moreno, Adrián Mural, Juan Doimi, Franco Giménez, Diana Rodríguez, Hernando Lora, Oscar Luciani, Silvana Broutet, Nathalie Darragh, Teresa Herrero, Rolando |
author |
Almonte, Maribel |
author_facet |
Almonte, Maribel Murillo, Jorge Raúl Sánchez, Gloria Inés González, Paula Ferrera, Annabelle Picconi, María Alejandra Wiesner, Carolina Cruz Valdez, Aurelio Lazcano Ponce, Eduardo Jerónimo, Jose Ferreccio, Catterina Kasamatsu, Elena Mendoza, Laura Rodríguez, Guillermo Calderón, Alejandro Venegas, Gino Villagra, Verónica Tatti, Silvio Alejandro Fleider, Laura Terán, Carolina Baena, Armando Hernández, María de la Luz Rol, Mary Luz Lucas, Eric Barbier, Sylvaine Ramírez, Arianis Tatiana Arrossi, Silvina Rodríguez, María Isabel González, Emmanuel Celis, Marcela Martínez, Sandra Salgado, Yuly Ortega, Marina Beracochea, Andrea Verónica Pérez, Natalia Rodriguez de la Peña, Margarita Mercedes Ramón, María Hernández Nevarez, Pilar Arboleda Naranjo, Margarita Cabrera, Yessy Salgado, Brenda García, Laura Retana, Marco Antonio Colucci, María Celeste Arias-Stella, Javier Bellido-Fuentes, Yenny Bobadilla, María Liz Olmedo, Gladys Brito García, Ivone Méndez Herrera, Armando Cardinal, Lucía Helena Flores, Betsy Peñaranda, Jhacquelin Martínez Better, Josefina Soilán, Ana Figueroa, Jacqueline Caserta, Benedicta Sosa, Carlos Moreno, Adrián Mural, Juan Doimi, Franco Giménez, Diana Rodríguez, Hernando Lora, Oscar Luciani, Silvana Broutet, Nathalie Darragh, Teresa Herrero, Rolando |
author_role |
author |
author2 |
Murillo, Jorge Raúl Sánchez, Gloria Inés González, Paula Ferrera, Annabelle Picconi, María Alejandra Wiesner, Carolina Cruz Valdez, Aurelio Lazcano Ponce, Eduardo Jerónimo, Jose Ferreccio, Catterina Kasamatsu, Elena Mendoza, Laura Rodríguez, Guillermo Calderón, Alejandro Venegas, Gino Villagra, Verónica Tatti, Silvio Alejandro Fleider, Laura Terán, Carolina Baena, Armando Hernández, María de la Luz Rol, Mary Luz Lucas, Eric Barbier, Sylvaine Ramírez, Arianis Tatiana Arrossi, Silvina Rodríguez, María Isabel González, Emmanuel Celis, Marcela Martínez, Sandra Salgado, Yuly Ortega, Marina Beracochea, Andrea Verónica Pérez, Natalia Rodriguez de la Peña, Margarita Mercedes Ramón, María Hernández Nevarez, Pilar Arboleda Naranjo, Margarita Cabrera, Yessy Salgado, Brenda García, Laura Retana, Marco Antonio Colucci, María Celeste Arias-Stella, Javier Bellido-Fuentes, Yenny Bobadilla, María Liz Olmedo, Gladys Brito García, Ivone Méndez Herrera, Armando Cardinal, Lucía Helena Flores, Betsy Peñaranda, Jhacquelin Martínez Better, Josefina Soilán, Ana Figueroa, Jacqueline Caserta, Benedicta Sosa, Carlos Moreno, Adrián Mural, Juan Doimi, Franco Giménez, Diana Rodríguez, Hernando Lora, Oscar Luciani, Silvana Broutet, Nathalie Darragh, Teresa Herrero, Rolando |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
COLPOSCOPY GYNAECOLOGICAL ONCOLOGY MOLECULAR DIAGNOSTICS PREVENTIVE MEDICINE PUBLIC HEALTH RISK MANAGEMENT |
topic |
COLPOSCOPY GYNAECOLOGICAL ONCOLOGY MOLECULAR DIAGNOSTICS PREVENTIVE MEDICINE PUBLIC HEALTH RISK MANAGEMENT |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Introduction Human papillomavirus (HPV) testing is replacing cytology in primary screening. Its limited specificity demands using a second (triage) test to better identify women at high-risk of cervical disease. Cytology represents the immediate triage but its low sensitivity might hamper HPV testing sensitivity, particularly in low-income and middle-income countries (LMICs), where cytology performance has been suboptimal. The ESTAMPA (EStudio multicéntrico de TAMizaje y triaje de cáncer de cuello uterino con pruebas del virus del PApiloma humano; Spanish acronym) study will: (1) evaluate the performance of different triage techniques to detect cervical precancer and (2) inform on how to implement HPV-based screening programmes in LMIC. Methods and analysis Women aged 30-64 years are screened with HPV testing and Pap across 12 study centres in Latin America. Screened positives have colposcopy with biopsy and treatment of lesions. Women with no evident disease are recalled 18 months later for another HPV test; those HPV-positive undergo colposcopy with biopsy and treatment as needed. Biological specimens are collected in different visits for triage testing, which is not used for clinical management. The study outcome is histological high-grade squamous intraepithelial or worse lesions (HSIL+) under the lower anogenital squamous terminology. About 50 000 women will be screened and 500 HSIL+ cases detected (at initial and 18 months screening). Performance measures (sensitivity, specificity and predictive values) of triage techniques to detect HSIL+ will be estimated and compared with adjustment by age and study centre. Ethics and dissemination The study protocol has been approved by the Ethics Committee of the International Agency for Research on Cancer (IARC), of the Pan American Health Organisation (PAHO) and by those in each participating centre. A Data and Safety Monitoring Board (DSMB) has been established to monitor progress of the study, assure participant safety, advice on scientific conduct and analysis and suggest protocol improvements. Study findings will be published in peer-reviewed journals and presented at scientific meetings. Trial registration number NCT01881659 Fil: Almonte, Maribel. International Agency For Research On Cancer; Francia Fil: Murillo, Jorge Raúl. Pontificia Universidad Javeriana; Colombia Fil: Sánchez, Gloria Inés. Universidad de Antioquia; Colombia Fil: González, Paula. Agencia Costarricense de Investigaciones Biomédicas; Costa Rica Fil: Ferrera, Annabelle. Universidad Nacional Autónoma de Honduras; Honduras Fil: Picconi, María Alejandra. Dirección Nacional de Institutos de Investigación. Administración Nacional de Laboratorios e Institutos de Salud. Instituto Nacional de Enfermedades Infecciosas; Argentina Fil: Wiesner, Carolina. Instituto Nacional de Cancerología; Colombia Fil: Cruz Valdez, Aurelio. Instituto de Salud Pública de México; México Fil: Lazcano Ponce, Eduardo. Instituto de Salud Pública de México; México Fil: Jerónimo, Jose. Liga Peruana de Lucha Contra El Cancer; Perú Fil: Ferreccio, Catterina. Pontificia Universidad Católica de Chile; Chile Fil: Kasamatsu, Elena. Universidad Nacional de Asunción; Paraguay Fil: Mendoza, Laura. Universidad Nacional de Asunción; Paraguay Fil: Rodríguez, Guillermo. Comisión Honoraria de Lucha Contra El Cáncer; Uruguay Fil: Calderón, Alejandro. Caja Costarricense de Seguro Social; Costa Rica Fil: Venegas, Gino. Clínica Anglo Americana; Perú. Universidad de Piura (udep); Perú Fil: Villagra, Verónica. Laboratorio Central de Salud Pública; Paraguay Fil: Tatti, Silvio Alejandro. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina Fil: Fleider, Laura. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina Fil: Terán, Carolina. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia Fil: Baena, Armando. International Agency for Research on Cancer; Francia Fil: Hernández, María de la Luz. Sms-oncology; Países Bajos. International Agency for Research on Cancer; Francia Fil: Rol, Mary Luz. International Agency for Research on Cancer; Francia Fil: Lucas, Eric. International Agency for Research on Cancer; Francia Fil: Barbier, Sylvaine. International Agency for Research on Cancer; Francia Fil: Ramírez, Arianis Tatiana. International Agency for Research on Cancer; Francia Fil: Arrossi, Silvina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Estudios de Estado y Sociedad; Argentina Fil: Rodríguez, María Isabel. Universidad Nacional de Asunción; Paraguay Fil: González, Emmanuel. Hospital Dr Enrique Baltodano Briceño; Costa Rica Fil: Celis, Marcela. Instituto Nacional de Cancerología; Colombia Fil: Martínez, Sandra. Instituto Nacional de Cancerología; Colombia Fil: Salgado, Yuly. Instituto Nacional de Cancerología; Colombia Fil: Ortega, Marina. Hospital Nacional; Paraguay. Ministerio de Salud Pública y Bienestar Social; Paraguay Fil: Beracochea, Andrea Verónica. Centro de Salud Ciudad de la Costa; Uruguay. Hospital Policial; Uruguay Fil: Pérez, Natalia. Hospital de Clinicas Dr. Manuel Quintela; Uruguay Fil: Rodriguez de la Peña, Margarita Mercedes. Hospital Nacional Profesor Alejandro Posadas; Argentina Fil: Ramón, María. Patología Oncológica Sac; Perú Fil: Hernández Nevarez, Pilar. Instituto de Salud Pública de México; México Fil: Arboleda Naranjo, Margarita. Instituto Colombiano de Medicina Tropical; Colombia Fil: Cabrera, Yessy. Universidad Nacional Autónoma de Honduras; Honduras Fil: Salgado, Brenda. Secretaría de Salud; Honduras Fil: García, Laura. Centro Hospitalario Pereira Rossell; Uruguay Fil: Retana, Marco Antonio. Caja Costarricense de Seguro Social; Costa Rica Fil: Colucci, María Celeste. Dirección Nacional de Institutos de Investigación. Administración Nacional de Laboratorios e Institutos de Salud. Instituto Nacional de Enfermedades Infecciosas; Argentina Fil: Arias-Stella, Javier. Instituto de Patología y Biología Molecular Arias Stella; Perú Fil: Bellido-Fuentes, Yenny. Liga Peruana de Lucha Contra El Cancer; Perú Fil: Bobadilla, María Liz. Laboratorio Central de Salud Pública; Paraguay Fil: Olmedo, Gladys. Laboratorio Central de Salud Pública; Paraguay Fil: Brito García, Ivone. Instituto de Salud Pública de México; México Fil: Méndez Herrera, Armando. Instituto de Salud Pública de México; México Fil: Cardinal, Lucía Helena. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina Fil: Flores, Betsy. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia Fil: Peñaranda, Jhacquelin. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia Fil: Martínez Better, Josefina. Ese Hospital Antonio Roldán Betancur; Colombia Fil: Soilán, Ana. Ministerio de Salud Pública y Bienestar Social; Paraguay. Hospital Nacional; Paraguay Fil: Figueroa, Jacqueline. Programa Nacional Contra El Cáncer; Honduras Fil: Caserta, Benedicta. Centro Hospitalario Pereira Rossell; Uruguay Fil: Sosa, Carlos. Hospital Monseñor Víctor Manuel Sanabria Martínez; Costa Rica Fil: Moreno, Adrián. Hospital Nacional Profesor Alejandro Posadas; Argentina Fil: Mural, Juan. Hospital Nacional Profesor Alejandro Posadas; Argentina Fil: Doimi, Franco. Patología Oncológica Sac; Perú Fil: Giménez, Diana. Ministerio de Salud Pública y Bienestar Social; Paraguay Fil: Rodríguez, Hernando. Ministerio de Salud Pública y Bienestar Social; Paraguay Fil: Lora, Oscar. Hospital Gineco-obstétrico y Neonatal "dr Jaime Sánchez Porcel"; Bolivia. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia Fil: Luciani, Silvana. Pan American Health Organization; Estados Unidos Fil: Broutet, Nathalie. Organizacion Mundial de la Salud; Argentina Fil: Darragh, Teresa. University of California; Estados Unidos Fil: Herrero, Rolando. Instituto Costarricense de Investigacion y Ensenanza En Nutricion y Salud Costa Rica; Costa Rica. International Agency For Research On Cancer; Francia |
description |
Introduction Human papillomavirus (HPV) testing is replacing cytology in primary screening. Its limited specificity demands using a second (triage) test to better identify women at high-risk of cervical disease. Cytology represents the immediate triage but its low sensitivity might hamper HPV testing sensitivity, particularly in low-income and middle-income countries (LMICs), where cytology performance has been suboptimal. The ESTAMPA (EStudio multicéntrico de TAMizaje y triaje de cáncer de cuello uterino con pruebas del virus del PApiloma humano; Spanish acronym) study will: (1) evaluate the performance of different triage techniques to detect cervical precancer and (2) inform on how to implement HPV-based screening programmes in LMIC. Methods and analysis Women aged 30-64 years are screened with HPV testing and Pap across 12 study centres in Latin America. Screened positives have colposcopy with biopsy and treatment of lesions. Women with no evident disease are recalled 18 months later for another HPV test; those HPV-positive undergo colposcopy with biopsy and treatment as needed. Biological specimens are collected in different visits for triage testing, which is not used for clinical management. The study outcome is histological high-grade squamous intraepithelial or worse lesions (HSIL+) under the lower anogenital squamous terminology. About 50 000 women will be screened and 500 HSIL+ cases detected (at initial and 18 months screening). Performance measures (sensitivity, specificity and predictive values) of triage techniques to detect HSIL+ will be estimated and compared with adjustment by age and study centre. Ethics and dissemination The study protocol has been approved by the Ethics Committee of the International Agency for Research on Cancer (IARC), of the Pan American Health Organisation (PAHO) and by those in each participating centre. A Data and Safety Monitoring Board (DSMB) has been established to monitor progress of the study, assure participant safety, advice on scientific conduct and analysis and suggest protocol improvements. Study findings will be published in peer-reviewed journals and presented at scientific meetings. Trial registration number NCT01881659 |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-05 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/174712 Almonte, Maribel; Murillo, Jorge Raúl; Sánchez, Gloria Inés; González, Paula; Ferrera, Annabelle; et al.; Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol; BMJ Publishing Group; BMJ Open; 10; 5; 5-2020; 1-14 2044-6055 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/174712 |
identifier_str_mv |
Almonte, Maribel; Murillo, Jorge Raúl; Sánchez, Gloria Inés; González, Paula; Ferrera, Annabelle; et al.; Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol; BMJ Publishing Group; BMJ Open; 10; 5; 5-2020; 1-14 2044-6055 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1136/bmjopen-2019-035796 info:eu-repo/semantics/altIdentifier/url/https://bmjopen.bmj.com/content/10/5/e035796 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
BMJ Publishing Group |
publisher.none.fl_str_mv |
BMJ Publishing Group |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268748537397248 |
score |
13.13397 |